Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: A RE-LY (randomized evaluation of long-term anticoagulation therapy) trial analysis"

Circulation

Volumn 130, Issue 22, 2014, Pages e195-

  Hijazi, Ziad ^a   Hohnloser, Stefan H ^b   Oldgren, Jonas ^a   Andersson, Ulrika ^a   Connolly, Stuart J ^c   Eikelboom, John W ^c   Ezekowitz, Michael D ^d   Reilly, Paul A ^e   Siegbahn, Agneta ^a   Yusuf, Salim ^c   Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DABIGATRAN; WARFARIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

BLEEDING; CEREBROVASCULAR ACCIDENT; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY FUNCTION; LETTER; MASS SPECTROMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; FEMALE; KIDNEY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HUMANS; KIDNEY; MALE; WARFARIN;

EID: 84916602087     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.012350     Document Type: Letter

References (3)

1. Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis. Circulation. 2014;129:961-970.
2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-2429
3. Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, Keltai M, Lanas F, Lopes RD, Lopez-Sendon J, Granger CB, Wallentin L. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012;33:2821-2830.